Singapore: China based CARsgen Therapeutics, a private and venture backed company focused on the development of CAR-T-ba...
Singapore: Actavis has recieved US Federal Trade Commission (FTC) nod to acquire Forest Laboratories following a propose...
Singapore: Leading Australian peptide drug discovery company Phylogica appointed Dr Richard Hopkins as the company's new...
Singapore: Kowa Pharmaceuticals and Eli Lilly released results from a pharmacokinetic (PK) study exploring potential dru...
Singapore: Taiwan based TWi Biotechnology has received patent allowance for AC-201, its lead drug candidate, from the Eu...
Tokyo: Japanese regenerative medicine company ReproCELL Inc. has announced the acquisition of the Scottish life science...
Singapore: Researchers from A*Star's Institute of Bioengineering and Nanotechnology (IBN) and IBM have unveiled first-e...
Singapore: Pfizer has launched Xalkori, a targeted therapy for ALK-positive non-small cell lung cancer (NSCLC), in Singa...
Singapore: Aslan Pharmaceuticals received approval by the Singapore Health Sciences Authority (HSA) for its Clinical Tri...
Singapore: Celsion Corporation, a fully-integrated oncology company focused on the development of a portfolio of innovat...
Singapore: Sihuan Pharmaceutical Holdings' roxatidine acetate hydrochloride for injection (Roxatidine), which is the com...
Singapore: Geneva based Drugs for Neglected Diseases and Japan's Takeda have collaborated for a Lead Optimization Progra...
Global life sciences company Abbott has announced that the company has observed positive clinical results from ABSORB Ja...
Singapore: Boehringer Ingelheim has achieved positive results from the trial of afatinib in comparison to erlotinib in p...
Singapore: Novartis has partnered with UK based Mereo BioPharma to develop compounds including BPS-804, to improve bone ...
Singapore: India based Jubilant Biosys, subsidiary of Jubilant Life Sciences, and Germany based Sanofi Deutschland have ...
Singapore: Amgen decided to stop the ganitumab (AMG 479) phase III GAMMA (gemcitabine and AMG 479 in metastatic adenocar...
NASDAQ-listed Minerva Neurosciences Inc, a clinical-stage biopharmaceutical company focused on the development of therap...
